Treatment and Outcome of Hemorrhagic Transformation After Intravenous Alteplase in Acute Ischemic Stroke
Published: November 02, 2017
- While symptomatic intracranial hemorrhage (sICH) is uncommon, it is the most feared complication of intravenous thrombolytic therapy in acute ischemic stroke.
- Treatment of sICH is currently based on expert opinion or small observational studies.
- This scientific statement provides an overview of sICH, discussing pathophysiology and treatment options.
Supporting Materials
- Commentary: Intracranial Hemorrhage After Stroke Thrombolysis: More Questions Than Answers by Shyam Prabhakaran, MD, MS
- Top Things to Know: Treatment and Outcome of Hemorrhagic Transformation After Intravenous Alteplase in Acute Ischemic Stroke
- Slide Set: Treatment and Outcome of Hemorrhagic Transformation After Intravenous Alteplase in AIS (PDF)